Recently, the Falspeed® peripheral vascular balloon dilatation catheter independently developed by Kossel Medtech has been approved by the National Medical Products Administration (NMPA) for marketing!

The approved Falspeed® Peripheral Vascular Dilation Catheter is the second peripheral intervention product of Kossel Medtech after Octoparms® Vena Cava Filter! It is mainly used for percutaneous transluminal angioplasty (PTA) of the peripheral vascular system (including iliac, femoral, popliteal, subgenital, and renal arteries), and is suitable for the treatment of occlusive lesions of natural or artificial dialysis arteriovenous fistulas .
The launch of Falspeed® has not only broadened the market in the peripheral interventional field of Kossel, but also provided more choices for clinical practice!

Kossel Medtech was a platform company with all-round production and research and development capabilities of vascular interventional devices, and is committed to providing clinical system solutions, with nearly 10,000 square meters of R&D and production bases, professional R&D and testing laboratories, systematic independent innovation R&D capabilities and leading manufacturing capabilities and nearly a hundred knowledge property. #PTA balloon catheter #Kossel Medtech